Akebia Therapeutics, Inc. (NASDAQ:AKBA) Released Earnings Last Week And Analysts Lifted Their Price Target To US$5.50

Yahoo FinanceNov 9 21:33

Akebia Therapeutics Prepares for Vafseo Launch

TipRanksNov 8 13:31

Akebia Therapeutics, Inc. (AKBA) Q3 2024 Earnings Call Transcript Summary

Futu NewsNov 8 03:02 · Conference Call

Akebia Therapeutics Shares Are Trading Lower After the Company Reported Worse-than-expected Q3 Financial Results.

BenzingaNov 7 21:54

Akebia GAAP EPS of -$0.10, Revenue of $37.4M

Seeking AlphaNov 7 20:20

Akebia Therapeutics | 10-Q: Quarterly report

SECNov 7 20:18 · Announcements